Huaben Bo

702 total citations
35 papers, 543 citations indexed

About

Huaben Bo is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Huaben Bo has authored 35 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Oncology and 12 papers in Immunology. Recurrent topics in Huaben Bo's work include CAR-T cell therapy research (8 papers), Metal complexes synthesis and properties (6 papers) and Immunotherapy and Immune Responses (6 papers). Huaben Bo is often cited by papers focused on CAR-T cell therapy research (8 papers), Metal complexes synthesis and properties (6 papers) and Immunotherapy and Immune Responses (6 papers). Huaben Bo collaborates with scholars based in China and Australia. Huaben Bo's co-authors include Jinquan Wang, Zizhuo Zhao, Xiaojuan Hao, Ke Lin, Qizhu Chen, Fenglin Wu, Han Shen, Hongwei Shao, Shulin Huang and Wenfeng Zhang and has published in prestigious journals such as PLoS ONE, Cancer and Journal of Agricultural and Food Chemistry.

In The Last Decade

Huaben Bo

33 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaben Bo China 14 231 226 118 87 42 35 543
Saswati Banerjee United States 13 257 1.1× 165 0.7× 99 0.8× 85 1.0× 58 1.4× 31 725
Liwen Wei China 14 209 0.9× 98 0.4× 93 0.8× 65 0.7× 33 0.8× 31 667
Csaba Hegedűs Hungary 16 296 1.3× 217 1.0× 85 0.7× 95 1.1× 58 1.4× 30 703
Beata Filip‐Psurska Poland 17 210 0.9× 209 0.9× 125 1.1× 64 0.7× 44 1.0× 44 734
Tasneem Kausar India 16 357 1.5× 230 1.0× 88 0.7× 41 0.5× 26 0.6× 34 668
Subhadip Das India 15 198 0.9× 72 0.3× 81 0.7× 93 1.1× 31 0.7× 39 567
Sheila Prachand United States 9 328 1.4× 184 0.8× 45 0.4× 46 0.5× 21 0.5× 20 572
Viviana C. Blank Argentina 10 186 0.8× 76 0.3× 110 0.9× 95 1.1× 46 1.1× 30 503
Zhengrong Shen China 17 384 1.7× 164 0.7× 122 1.0× 25 0.3× 53 1.3× 40 744

Countries citing papers authored by Huaben Bo

Since Specialization
Citations

This map shows the geographic impact of Huaben Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaben Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaben Bo more than expected).

Fields of papers citing papers by Huaben Bo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaben Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaben Bo. The network helps show where Huaben Bo may publish in the future.

Co-authorship network of co-authors of Huaben Bo

This figure shows the co-authorship network connecting the top 25 collaborators of Huaben Bo. A scholar is included among the top collaborators of Huaben Bo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaben Bo. Huaben Bo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Zhijie, et al.. (2025). Nucleus-targeted ruthenium(II) complex triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy by activating cGAS–STING pathway. Journal of Inorganic Biochemistry. 267. 112871–112871. 4 indexed citations
2.
Shi, Wen-Kai, Hui Zhong, Wenfeng Zhang, et al.. (2025). miR-143-3p Promotes TSCM Differentiation and Inhibits Progressive T Cell Differentiation via Inhibiting ABL2 and PAG1. Genes. 16(4). 466–466.
3.
Han, Jiayi, Jianqing Huang, Wen-Kai Shi, et al.. (2024). miR-744-5p promotes T-cell differentiation via inhibiting STK11. Gene. 926. 148635–148635. 1 indexed citations
4.
Chen, Lu, Rui Wang, Min Deng, et al.. (2024). Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection. Virology. 597. 110142–110142. 1 indexed citations
6.
Chen, Dan, Xiaohong Chen, He Cai, et al.. (2023). Sanhuang xiexin decoction synergizes insulin/PI3K-Akt/FoxO signaling pathway to inhibit hepatic glucose production and alleviate T2DM. Journal of Ethnopharmacology. 306. 116162–116162. 18 indexed citations
7.
Chen, Dan, et al.. (2022). Mechanisms of Danggui Buxue Tang on Hematopoiesis via Multiple Targets and Multiple Components: Metabonomics Combined with Database Mining Technology. The American Journal of Chinese Medicine. 50(4). 1155–1171. 4 indexed citations
8.
Ye, Ting, Bin Zhang, Jing Liu, et al.. (2022). Chemokine CCL17 Affects Local Immune Infiltration Characteristics and Early Prognosis Value of Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 10. 816927–816927. 16 indexed citations
9.
Chen, Dan, Huaben Bo, Han Shen, et al.. (2022). Combination of ruthenium (II) polypyridyl complex Δ-Ru1 and Taxol enhances the anti-cancer effect on Taxol-resistant cancer cells through Caspase-1/GSDMD-mediated pyroptosis. Journal of Inorganic Biochemistry. 230. 111749–111749. 26 indexed citations
10.
Chen, Jun, et al.. (2021). Gut microbiota affects the efficacy of Danggui Buxue Tang by affecting plasma concentration of active ingredients. Journal of Ethnopharmacology. 270. 113835–113835. 6 indexed citations
11.
Liu, Jing, Bin Zhang, Ting Ye, et al.. (2021). Prognostic modeling of patients with metastatic melanoma based on tumor immune microenvironment characteristics. Mathematical Biosciences & Engineering. 19(2). 1448–1470. 5 indexed citations
12.
Jia, Lihong, Chunyan Huang, Qizhu Chen, et al.. (2020). Danggui Buxue Tang restores antibiotic-induced metabolic disorders by remodeling the gut microbiota. Journal of Ethnopharmacology. 259. 112953–112953. 23 indexed citations
13.
Wang, Hui, Hua Lu, Zhao Chen, et al.. (2020). Development of a Self-Restricting CRISPR-Cas9 System to Reduce Off-Target Effects. Molecular Therapy — Methods & Clinical Development. 18. 390–401. 14 indexed citations
14.
Lin, Ke, Yi Rong, Dan Chen, et al.. (2020). Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway. Frontiers in Oncology. 10. 141–141. 32 indexed citations
15.
Wang, Xiao, et al.. (2019). Metabolomic analysis of serum reveals the potential effective ingredients and pathways of Danggui Buxue Tang in promoting erythropoiesis. Complementary Therapies in Medicine. 48. 102247–102247. 10 indexed citations
16.
Bo, Huaben, Xiao Wang, Jun Chen, et al.. (2018). Danggui Buxue Tang promotes the adhesion and migration of bone marrow stromal cells via the focal adhesion pathway in vitro. Journal of Ethnopharmacology. 231. 90–97. 19 indexed citations
17.
Lin, Ke, Zizhuo Zhao, Huaben Bo, Xiaojuan Hao, & Jinquan Wang. (2018). Applications of Ruthenium Complex in Tumor Diagnosis and Therapy. Frontiers in Pharmacology. 9. 1323–1323. 129 indexed citations
18.
Chen, Jun, et al.. (2017). Effect of Danggui Buxue Tang on Erythropoiesis in Acute Chemotherapy Injured Mice. International Journal of Pharmacology. 13(6). 583–592. 5 indexed citations
19.
Shao, Hongwei, Teng Wang, Han Shen, et al.. (2014). Differences in TCR-Vβ Repertoire and Effector Phenotype between Tumor Infiltrating Lymphocytes and Peripheral Blood Lymphocytes Increase with Age. PLoS ONE. 9(7). e102327–e102327. 14 indexed citations
20.
Bo, Huaben, Jinquan Wang, Qizhu Chen, et al.. (2012). Using a single hydrophobic-interaction chromatography to purify pharmaceutical-grade supercoiled plasmid DNA from other isoforms. Pharmaceutical Biology. 51(1). 42–48. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026